Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
Andrea Santamato Physical Medicine and Rehabilitation Section, “OORR Hospital,” University of Foggia, Foggia, Italy Abstract: Spasticity is a common disabling symptom for several neurological conditions. Botulinum toxin type A injection represents the gold standard treatment fo...
Enregistré dans:
Auteur principal: | Santamato A |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a46c4cff9f314e0cb8b6987eb9ab881e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: A review of the science, the clinical data, and patient satisfaction
par: Koenraad De Boulle, et autres
Publié: (2010) -
Muscle Selection and Dosing in a Phase 3, Pivotal Study of AbobotulinumtoxinA Injection in Upper Limb Muscles in Children With Cerebral Palsy
par: Joyce Oleszek, et autres
Publié: (2021) -
Localization of the Centers of Intramuscular Nerve Dense Regions of the Rotator Cuff Muscles: A Guide for Botulinum Toxin A Injection for Spasticity Accompanied by Shoulder Pain
par: Luo,Huaixiang, et autres
Publié: (2020) -
AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
par: Mark F. Lew, et autres
Publié: (2021) -
Caregiver burden, productivity loss, and indirect costs associated with caring for patients with poststroke spasticity
par: Ganapathy V, et autres
Publié: (2015)